GL1X · GenesisL1 explorer

Research workbench

Crystal structure of V30M mutated transthyretin in complex with alpha- mangostin

Analyse Crystal structure of V30M mutated transthyretin in complex with alpha- mangostin in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4Y9B
Type
protein
Length
231 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
MKS, CA, CL
Pockets
3 · best druggability 0.37

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransthyretinprotein1166% helix, 51% strandP02766
BTransthyretinprotein1156% helix, 51% strandP02766

Ligands and binding sites

  • MKS · 1,3,6-trihydroxy-7-methoxy-2,8-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one · ligand · 2 copies · chains A, B
  • CA · Calcium ion · metal · chains A
  • CL · Chloride ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1840.370.7616empty
2920.360.7516empty
3630.260.7218empty

Interfaces

1 interface between chains.

  • A–B · 917 Ų buried · 22 hydrogen bonds · protein-protein

Compared structures

  • 4Y9B · Crystal structure of V30M mutated transthyretin in complex with alpha-mangostin · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.